Dynavax Technologies
DVAX
#4961
Rank
A$2.55 B
Marketcap
A$21.76
Share price
0.00%
Change (1 day)
3.07%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -A$58.75 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are A$0.33 Billion. In 2024 the company made an earning of A$52.84 Million, an increase over its 2023 earnings that were of A$3.35 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$58.75 Million-211.16%
2024 A$52.84 M1475.31%
2023 A$3.35 M-99.2%
2022 A$0.42 B238.78%
2021 A$0.12 B-257.89%
2020 -A$78.86 Million-58.58%
2019 -A$0.2 Billion-9.32%
2018 -A$0.21 Billion60.44%
2017 -A$0.14 Billion-15.8%
2016 -A$0.16 Billion4.22%
2015 -A$0.15 Billion16.54%
2014 -A$0.13 Billion37.09%
2013 -A$93.33 Million
2010 -A$66.81 Million214.85%
2009 -A$21.22 Million-37.33%
2008 -A$33.86 Million-66.07%
2007 -A$99.8 Million16.92%
2006 -A$85.35 Million170.36%
2005 -A$31.57 Million33.39%
2004 -A$23.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$16.63 B-35,074.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$11.57 B-24,427.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.67 B-5,718.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$13.87 B-29,272.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$32.41 B-68,236.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$18.37 B-38,727.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$13.08 B-27,610.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
A$29 M-160.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.02 B-6,450.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel